← Back to Search

Device

Atrial fibrillation (AFib) for Atrial Fibrillation

N/A
Waitlist Available
Research Sponsored by Omron Healthcare Co., Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial tests how well an Omron BP monitor with AFib screening feature can accurately measure blood pressure and identify abnormal heart rhythms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity
Specificity

Trial Design

2Treatment groups
Active Control
Group I: Atrial fibrillation (AFib)Active Control2 Interventions
Patient with known history of AFib who are in AFib at the time of study screening.
Group II: Non-AfibActive Control2 Interventions
Patient with no known diagnosis of AFib

Find a Location

Who is running the clinical trial?

Omron Healthcare Co., Ltd.Lead Sponsor
13 Previous Clinical Trials
26,953 Total Patients Enrolled
ICON plcIndustry Sponsor
80 Previous Clinical Trials
24,572 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any Canadian facilities administering this medical research?

"This study's recruitment is being held at five distinct medical centres, including Accelacare of MacFarland Clinic in Ames, Accelacare of Charleston in Charleston and Accelacare of DuPage Medical Group in Winfield. Additionally there are two additional sites participating."

Answered by AI

Is this experiment actively recruiting participants?

"The trial is currently in the recruitment phase. Clinicaltrials.gov declares that it was initially made available on September 6th 2022 and has since been updated as of October 25th 2021."

Answered by AI

What is the current count for participants in this medical research?

"This clinical trial requires 600 participants who meet certain criteria to take part. Individuals can join the research at Accelacare of MacFarland Clinic in Ames, Iowa or Accelacare of Charleston in Charleston, South carolina."

Answered by AI
~222 spots leftby Apr 2025